Two studies show that fewer men have been screened for prostate cancer using the PSA test since 2012, when a federal panel advised against routine screenings. With doctors increasingly questioning the test's validity, that's a good thing. But the real key is whether reduction in PSA testing has led to a rise in late-stage or fatal prostate cancer. Continue reading
The post Fewer Men Getting Prostate Test, Following US Advisory appeared first on American Council on Science and Health.
